- NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
-
Caldwell S
- KMID: 2413111
- Clin Mol Hepatol.
- 2017 Jun;23(2):103-108.
- doi: 10.3350/cmh.2017.0103
Non-alcoholic steatohepatitis (NASH) is the more aggressive form of non-alcoholic fatty liver disease (NAFLD). NASH can progress to hepatic fibrosis, cirrhosis, portal hypertension and primary liver cancer. Therapy is evolving... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
-
Kim GH, Chung JW, Lee JH, Ok KS, Jang ES, Kim J, Shin CM, Park YS, Hwang JH, Jeong SH, Kim N, Lee DH, Kim JW
- KMID: 2359820
- Clin Mol Hepatol.
- 2015 Dec;21(4):379-386.
- doi: 10.3350/cmh.2015.21.4.379
BACKGROUND/AIMS: Vitamin E improves the biochemical profiles and liver histology in nonalcoholic steatohepatitis, but the role of vitamin E is not clearly defined in the management of nonalcoholic fatty liver... -
- CITED
-
- Close
- SHARE
-
- Close
